Short Communication: Higher Tenofovir Concentrations in Hair Are Associated with Decreases in Viral Load and Not Self-Reported Adherence in HIV-Infected Adolescents with Second-Line Virological Treatment Failure - PubMed (original) (raw)

Randomized Controlled Trial

. 2021 Oct;37(10):748-750.

doi: 10.1089/AID.2020.0258. Epub 2021 Feb 24.

Affiliations

Randomized Controlled Trial

Short Communication: Higher Tenofovir Concentrations in Hair Are Associated with Decreases in Viral Load and Not Self-Reported Adherence in HIV-Infected Adolescents with Second-Line Virological Treatment Failure

Tariro Chawana et al. AIDS Res Hum Retroviruses. 2021 Oct.

Abstract

Objective methods of measuring antiretroviral adherence are limited. We assessed the relationship between tenofovir disoproxil fumarate (TDF) hair concentrations, self-reported adherence, and virological outcomes in HIV-infected adolescents in Harare, Zimbabwe. HIV-infected adolescents on atazanavir/ritonavir-based second-line treatment for >6 months with viral load (VL) ≥1,000 copies/mL were randomized to either modified directly administered antiretroviral therapy (mDAART) or standard of care. Hair and VL samples were collected at baseline and after 90 days. Treatment outcome was defined as TDF concentrations in hair. Virological suppression was defined as VL <1,000 copies/mL. Thirty-four adolescents had TDF concentrations measured at baseline and follow-up. Mean (median); range age was 16 (16); 13-18 years and 53% were females. Nineteen (56%) were randomized to mDAART. Mean (SD); range TDF concentrations were 0.03 (0.04); 0-0.17 ng/mg hair and 0.06 (0.06); 0-0.3 ng/mg hair at baseline and follow-up, respectively. Higher TDF concentrations were associated with decreased VL [regression coefficient (RC) 0.8; 95% confidence interval (CI) 0.7-1.0; p = .008] and mDAART (RC 0.5; 95% CI 0.3-1.0; p = .04), but were not associated with self-reported adherence and virological suppression (VL <1,000 copies/mL). Higher TDF hair concentrations were observed with virological decrease and an adherence intervention. Hair antiretroviral concentrations could be useful in triggering adherence interventions among adolescents with second-line virological failure.

Keywords: adolescents; tenofovir hair concentrations; virological treatment failure.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

References

    1. Baxi SM, Liu A, Bacchetti P, et al. : Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr 2015;68:13–20. -PMC -PubMed
    1. Spinelli MA, Haberer JE, Chai PR, Castillo-Mancilla J, Anderson PL, Gandhi M: Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions. Curr HIV/AIDS Rep 2020;17:301–314. -PMC -PubMed
    1. Murnane PM, Bacchetti P, Currier JS, et al. : Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS 2019;33:1657–1662. -PMC -PubMed
    1. Chawana TD, Gandhi M, Nathoo K, et al. : Defining a cutoff for atazanavir in hair samples associated with virological failure among adolescents failing second-line antiretroviral treatment. J Acquir Immune Defic Syndr 2017;76:55–59. -PMC -PubMed
    1. Donnell D, Baeten JM, Bumpus NN, et al. : HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr 2014;66:340–348. -PMC -PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources